OBI Pharma Inc - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of the page for potential risks for OBI Pharma Inc based on industry, geography and marketcap. Other corporations in the rating industry group for OBI Pharma Inc are shown below. This dashboard contains a questions and answers section on OBI Pharma Inc.
OBI Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 2.0, social score of 8.0 and governance score of 6.4.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 602 | SkinBioTherapeutics PLC | 5.6 | High |
| 602 | XOMA Corp | 5.6 | High |
| 627 | OBI Pharma Inc | 5.5 | High |
| 627 | Advanced Medical Solutions Group PLC | 5.5 | High |
| 627 | Achieve Life Sciences Inc | 5.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does OBI Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes OBI Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes OBI Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes OBI Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes OBI Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes OBI Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes OBI Pharma Inc offer flexible work?
Sign up for free to unlockDoes OBI Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes OBI Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes OBI Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes OBI Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes OBI Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes OBI Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes OBI Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes OBI Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes OBI Pharma Inc disclose water use targets?
Sign up for free to unlockDoes OBI Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid OBI Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes OBI Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes OBI Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas OBI Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes OBI Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes OBI Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes OBI Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes OBI Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes OBI Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes OBI Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes OBI Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs OBI Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes OBI Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes OBI Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes OBI Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes OBI Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes OBI Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes OBI Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes OBI Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for OBI Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immuno-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-898 SSEA4, a passive immunity monoclonal antibody; OBI-998 SSEA4, an antibody small molecule drug complex, which targets toxic drugs to malignant tumors; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a clostridium botulinum toxin. The company was founded in 2002 and is based in Taipei, Taiwan.